Conference
B1-01: A multi-centre phase IIB randomized controlled study of BLP25 liposome vaccine (L-BLP25 or Stimuvax) for active specific immunotherapy of non-small cell lung cancer (NSCLC): updated survival analysis
Authors
Butts C; Maksymiuk A; Goss G; Soulieres D; Marshall E; Cormier Y; Ellis PM; Price A; Sawhney R; Murray N
Volume
2
Pagination
pp. s332-s333
Publisher
Elsevier
Publication Date
August 1, 2007
DOI
10.1097/01.jto.0000283139.22682.5e
Conference proceedings
Journal of Thoracic Oncology
Issue
8
ISSN
1556-0864